Aug 2026· Case Reports in Oncology· Vol 19, pp. 1594 - 1600· 0 citations· 9 references
Medicine
TL;DR
ITTC should be considered in the differential diagnosis of thyroid nodules with suspicious ultrasound features, especially when associated with cervical lymph node metastases, especially when associated with cervical lymph node metastases.
Abstract
Abstract Introduction Intrathyroidal thymic carcinoma (ITTC) is a rare low-grade malignant tumor arising within the thyroid gland. It exhibits histological and immunophenotypic features similar to thymic carcinoma. Due to its rarity and non-specific imaging findings, preoperative diagnosis remains challenging. Case Presentation We report a case of a 60-year-old male who presented with hoarseness and dysphagia. Ultrasound revealed multiple bilateral thyroid nodules with irregular margins and heterogeneous internal echoes, along with bilateral cervical lymphadenopathy. Enhanced CT showed heterogeneous enhancement of the thyroid and enlarged lymph nodes. The patient underwent extended radical resection of bilateral thyroid cancer with mediastinal lymph node dissection. Postoperative pathology and immunohistochemistry confirmed the diagnosis of bilateral thyroid thymic carcinoma with multiple cervical lymph node metastases. Conclusion ITTC should be considered in the differential diagnosis of thyroid nodules with suspicious ultrasound features, especially when associated with cervical lymph node metastases. Positive expression of CD5 and CD117 with negative expression of Tg and TTF-1 is diagnostic. Treatment follows principles similar to those for thymic carcinoma, and complete surgical resection remains the mainstay.
Background Synchronous medullary thyroid carcinoma (MTC) and papillary thyroid carcinoma (PTC) are uncommon thyroid malignancies, whereas mixed-component cervical lymph node metastases containing both tumor components within the same metastatic deposit are exceptionally rare. This case highlights the diagnostic value o...
Yi-Fan He, Cheng Fu, Ya-Wen Bai et al.· Gland surgery· 0 citations
Background and Clinical Significance: Thyroid metastasis from clear cell renal cell carcinoma (ccRCC) is uncommon and may occur after radical nephrectomy despite no evidence of residual or metastatic disease at that time. Diagnosis can be challenging because imaging and fine-needle aspiration (FNA) may mimic benign or...
Constantinos Papadopoulos, K. Dinaki, Rafail Ioannidis et al.· Reports· 0 citations
The findings suggest that DSV-PTC can behave aggressively in pediatric patients and can mimic benign inflammatory conditions, leading to potential diagnostic delays, appear vital for managing this challenging variant.
Şafak Demirtaş, Z. Şıklar, E. Özsu et al.· Journal of Pediatric Endocri...· 0 citations
Introduction: Mixed medullary and follicular-cell derived carcinoma (MMFCC) is an exceptionally rare thyroid malignancy, accounting for less than 0.1% of all thyroid malignancies, defined by the coexistence of morphologically distinct follicular and C-cell-derived populations. Diagnosis is difficult when bone metastasi...
Ignatius Ferdi Yuatmadja, H. Saputra· Indonesian Journal of Cancer· 0 citations
Background Primary malignant melanoma of the uterine cervix (PMMC) is an exceptionally rare mucosal malignancy with an aggressive clinical behavior and no established standard of care. Distinguishing a primary cervical melanoma from metastatic disease is particularly challenging and requires integration of pathological...
A. Filipescu, A. Cioca, Alex Gabriel Strajean et al.· Frontiers in Oncology· 0 citations
Background Primary breast lymphoma (PBL) is an exceedingly rare extranodal malignancy that frequently mimics breast carcinoma on clinical and radiological examination, posing a significant diagnostic challenge. Case presentation We report a case of a 39-year-old Chinese woman who presented with two palpable right breas...
Ren-Da Jiang, Da-Lei Chen, Lu-Ning Wu et al.· Frontiers in Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.